Solving Biological Mysteries Through Pattern Recognition

Immunologist Derya Unutmaz utilized GPT-5 Pro to resolve a three-year-old experimental anomaly regarding T cell specialization. His team previously observed that T cells exposed to deoxyglucose—a glucose-like molecule—consistently differentiated into inflammatory Th17 cells, whereas low-glucose environments did not produce the same effect. The team could not determine the underlying mechanism and shelved the data.

When re-analyzed by the model, the AI identified that deoxyglucose specifically interfered with the production of IL-2, a protein that normally acts as a barrier to Th17 differentiation. By removing this protein, the cells were effectively pushed toward an inflammatory state. This insight was outside the immediate scope of the lab's expertise, demonstrating the model's ability to synthesize complex biological interactions that human researchers may overlook.

AI as a Strategic Research Collaborator

Beyond retrospective analysis, Unutmaz uses the model to simulate experiments before conducting them in the lab. This approach serves two primary functions:

  • Hypothesis Prioritization: Researchers face a vast number of potential experimental paths. By simulating outcomes, the model helps scientists narrow down which strategies are most likely to yield significant results, potentially saving months of trial-and-error.
  • Predictive Validation: In a blind test, the model correctly predicted the enhanced cancer-killing capabilities of CD8+ T cells in a lymphoma study that had not yet been published or indexed on the internet. This suggests the model is performing genuine reasoning rather than simple retrieval.

The Human-in-the-Loop Requirement

Despite these capabilities, Unutmaz emphasizes that subject matter expertise remains non-negotiable. The AI provides the insight, but the human researcher must evaluate its biological plausibility and significance. The model acts as a force multiplier—streamlining literature reviews and data synthesis—but the scientist remains the final arbiter of the research direction. This collaborative workflow allows for the rapid generation of complex materials, such as large-scale mutation datasets and specialized textbooks, which would otherwise require significant manual labor.